Metoprolol Succinate

Overview

Metoprolol Succinate is a selective beta1 receptor blocker used to treat high blood pressure and angina, and to improve survival after a heart attack. It is often used in the extended-release form for heart-related conditions.

API suppliers (14)

Suppliers of Metoprolol Succinate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• MOEHS IBERICA SLSpain1 active DMF GMP on record
• Zhejiang Hisoar Pharmaceutical Co., Ltd.China1 active DMF
• TAPI NL BVNetherlands1 active DMF
• YUNG ZIP CHEMICAL IND CO LTD1 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• Hetero Drugs LimitedIndia1 active DMF GMP on record
• Arevipharma GmbHGermany GMP on record
• POLYDRUG LABORATORIES PVT LTD
• AARTI DRUGS LTDIndia GMP on record
• ZENTIVA KSCzechia GMP on record
• MEDICHEM SASpain GMP on record
• Ipca Laboratories LimitedIndia GMP on record
• ESTEVE QUIMICA SA GMP on record
• ZAKLADY FARMACEUTYCZNE POLPHARMA SA

EU CEP holders (13)

Companies holding a valid EU Certificate of Suitability (CEP) for Metoprolol Succinate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas